Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

AAN Congress 2022

Seattle, WA, 2-7 April 2022

 

Discover updates in the world of neurology!

The 74th annual American Academy of Neurology (AAN) 2022 annual meeting took place on 2-7 April 2022 in Seattle, WA.

Featuring talks on the most recent research across a multitude of disciplines in neurology – discussions on controversies, clinical trials and biology are discussed at this globally captivating meeting.

Explore the latest updates presented at AAN 2022 right here!

What's new?

View all
1:38
Challenges in the differential diagnosis of NMOSD from MS
Michael Levy • 3 Apr 2022
2:44
Improving ALS diagnosis: the Gold Coast criteria and the role of TMS
Matthew Kiernan • 4 Apr 2022
4:24
Ongoing trials with importance for Huntington’s disease
Jee Bang • 4 Apr 2022
2:05
Long term safety and efficacy data for ravulizumab in AChR Ab+ generalized myasthenia gravis
James F. Howard Jr. • 12 Apr 2022

Epilepsy

View all
1:28
Novel agents to control seizures & target epileptogenesis
Claude Steriade • 24 Mar 2022
2:38
Cognitive and psychiatric adverse events associated with cenobamate
William E. Rosenfeld • 4 Apr 2022
1:26
Issues concerning the treatment of PNES
William Curt LaFrance Jr • 4 Apr 2022
2:57
Neurological care of adults with intellectual developmental disabilities
Seth Keller • 3 Apr 2022

Stroke

View all
2:33
Upcoming developments in stroke
Dileep Yavagal • 3 Apr 2022
3:11
Goals of the TALENTS program: Training Africans to Lead and Execute Neurological Trials & Studies
Bruce Ovbiagele • 12 Apr 2022
3:50
Advancements in stroke systems of care
Johanna Fifi • 3 Apr 2022
7:58
Should anticoagulation be restarted after ICH for stroke prevention in atrial fibrillation?
Edip Gurol • 2 Apr 2022

Headache

View all
1:48
Personalized treatment in migraine prevention
Yi-Chieh Chen • 5 Apr 2022
4:46
A pilot study of the effect of pharmacogenomic data on dosages of verapamil for migraine prevention
Yi-Chieh Chen • 5 Apr 2022
3:31
Pontine-hypothalamic interplay for predicting migraine progression
Roberta Messina • 13 Apr 2022
1:01
Future work on pharmacogenomic testing in migraine
Yi-Chieh Chen • 5 Apr 2022

Sleep Disorders

View all
3:28
Current understanding of the pathophysiology of RBD
Alberto Ramos • 12 Apr 2022
3:03
Cognitive behavioral therapy is the gold standard treatment for insomnia
Michelle Jonelis • 28 Mar 2022

Multiple Sclerosis and Related Disorders

View all
1:51
Selecting treatment options for NMOSD
Michael Levy • 3 Apr 2022
2:47
Why is personalized medicine important in multiple sclerosis?
Jean-Pierre Falet • 22 Mar 2022
The content of VJNeurology is intended for healthcare professionals